US0303711081 - Common Stock

**AVD** gets a fundamental rating of **3** out of 10. The analysis compared the fundamentals against 84 industry peers in the **Chemicals** industry. **AVD** scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. **AVD** is quite expensive at the moment. It does show a decent growth rate.

In the past year **AVD** has reported a negative cash flow from operations.

Of the past 5 years **AVD** 4 years had a positive operating cash flow.

Looking at the **Return On Assets**, with a value of **-0.43%**, **AVD** is doing worse than **66.67%** of the companies in the same industry.

Looking at the **Return On Equity**, with a value of **-0.99%**, **AVD** is doing worse than **63.10%** of the companies in the same industry.

Looking at the **Return On Invested Capital**, with a value of **2.84%**, **AVD** is doing worse than **61.90%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | -0.43% | ||

ROE | -0.99% | ||

ROIC | 2.84% |

ROA(3y)2.48%

ROA(5y)2.34%

ROE(3y)4.81%

ROE(5y)4.52%

ROIC(3y)4.94%

ROIC(5y)4.23%

In the last couple of years the **Profit Margin** of **AVD** has declined.

The **Operating Margin** of **AVD** (**3.86%**) is worse than **67.86%** of its industry peers.

Looking at the **Gross Margin**, with a value of **30.41%**, **AVD** is in line with its industry, outperforming **59.52%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 3.86% | ||

PM (TTM) | N/A | ||

GM | 30.41% |

OM growth 3Y1.8%

OM growth 5Y-13.38%

PM growth 3Y-26.84%

PM growth 5Y-24.6%

GM growth 3Y-6.33%

GM growth 5Y-5.11%

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), **AVD** is destroying value.

The number of shares outstanding for **AVD** has been reduced compared to 1 year ago.

The number of shares outstanding for **AVD** has been reduced compared to 5 years ago.

Compared to 1 year ago, **AVD** has a worse debt to assets ratio.

A Debt/Equity ratio of **0.60** indicates that **AVD** is somewhat dependend on debt financing.

With a **Debt to Equity ratio** value of **0.60**, **AVD** perfoms like the industry average, outperforming **51.19%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.6 | ||

Debt/FCF | N/A | ||

Altman-Z | 1.98 |

ROIC/WACC0.3

WACC9.48%

A Current Ratio of **2.22** indicates that **AVD** has no problem at all paying its short term obligations.

A Quick Ratio of **1.08** indicates that **AVD** should not have too much problems paying its short term obligations.

Looking at the **Quick ratio**, with a value of **1.08**, **AVD** is doing worse than **65.48%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 2.22 | ||

Quick Ratio | 1.08 |

The earnings per share for **AVD** have decreased strongly by **-133.00%** in the last year.

Measured over the past years, **AVD** shows a very negative growth in **Earnings Per Share**. The EPS has been decreasing by **-20.52%** on average per year.

Looking at the last year, **AVD** shows a small growth in **Revenue**. The Revenue has grown by **2.64%** in the last year.

The **Revenue** has been growing slightly by **4.98%** on average over the past years.

EPS 1Y (TTM)-133%

EPS 3Y-11.88%

EPS 5Y-20.52%

EPS Q2Q%-950%

Revenue 1Y (TTM)2.64%

Revenue growth 3Y8.1%

Revenue growth 5Y4.98%

Sales Q2Q%-3.45%

The **Earnings Per Share** is expected to grow by **23.87%** on average over the next years. This is a very strong growth

EPS Next Y-222.37%

EPS Next 2Y23.87%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year-1.37%

Revenue Next 2Y1.61%

Revenue Next 3YN/A

Revenue Next 5YN/A

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

65.48% of the companies in the same industry are more expensive than **AVD**, based on the **Price/Forward Earnings** ratio.

Compared to an average S&P500 **Price/Forward Earnings** ratio of **23.71**, **AVD** is valued a bit cheaper.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | N/A | ||

Fwd PE | 14.46 |

Based on the **Enterprise Value to EBITDA** ratio, **AVD** is valued cheaper than 82.14% of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | N/A | ||

EV/EBITDA | 8.13 |

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y23.87%

EPS Next 3YN/A

With a **Yearly Dividend Yield** of **2.15%**, **AVD** has a reasonable but not impressive dividend return.

Compared to an average industry **Dividend Yield** of **2.85**, **AVD** pays a bit more dividend than its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 2.15% |

The dividend of **AVD** is nicely growing with an annual growth rate of **9.54%**!

Dividend Growth(5Y)9.54%

Div Incr Years3

Div Non Decr Years3

DP-96.1%

EPS Next 2Y23.87%

EPS Next 3YN/A

**AMERICAN VANGUARD CORP**

NYSE:AVD (11/8/2024, 8:04:00 PM)

After market: 5.77 0 (0%)**5.77**

**+0.19 (+3.41%) **

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryChemicals

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap166.41M

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 2.15% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | N/A | ||

Fwd PE | 14.46 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | -0.43% | ||

ROE | -0.99% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 3.86% | ||

PM (TTM) | N/A | ||

GM | 30.41% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.72

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.6 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 2.22 | ||

Quick Ratio | 1.08 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)-133%

EPS 3Y-11.88%

EPS 5Y

EPS Q2Q%

EPS Next Y-222.37%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)2.64%

Revenue growth 3Y8.1%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y